HeyJaredScience & Medicine
Interesting topics ranging from marijuana, to space, to viruses, pandemics, and immunity, to science behind anything and everything, such as stress, climate change, and AI
- Indexed episodes, last 90 days
- 1
- Latest publication
- Aug 27, 2026
- Audience
- Checking…
- Earliest in this view
- Aug 27, 2026
Latest episodes
Alzheimer’s (opens the original)
Read excerpt
The US Food and Drug Administration is expected to decide whether to grant traditional approval to the Alzheimer’s drug Leqembi, the first medicine proven to slow the course of the memory-robbing disease. An approval decision would also be expected to trigger a change in how the Centers for Medicare and Medicaid Services covers the drug, broadening access for up to an estimated million people with early forms of the disease. Ed examines what this may mean to millions of people.
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.